Reset filters
10 December 2024

Overnight inpatient monitoring is common following balloon pulmonary angioplasty (BPA) for chronic thromboembolic pulmonary hypertension (CTEPH). We describe our institutional experience in same-day discharge (SDD) after BPA. Across 78 BPA sessions, there were only 2 (2.6%) admissions for hemoptysis with no reperfusion lung injury or deaths at 30 days.

Pulmonary Circulation
4 December 2024

Long-term hypoxia is one of the main causes of pulmonary vascular remodeling in pulmonary hypertension (PH) associated with congenital heart disease (CHD) children. Endothelial to mesenchymal transition (EndMT) is an important pathological basis of pulmonary vascular remodeling in PH. 

Pulmonary Circulation
27 November 2024

'Co-Infection' is part of the Microbes Virtual Symposium series by the iPVD, a global education programme that highlights top-notch research on inflammation and infectious PVD.

IDDI Workstream or Task Force Learning
24 November 2024

Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant, multisystem disorder that manifests with a spectrum of disease including cardiopulmonary complications. HHT is characterised by aberrant signalling via the transforming growth factor β (TGFβ) pathway, with loss of vascular integrity, angiogenesis and vascular dysplasia. The disease has an estimated prevalence of 1 in 5000 persons and the penetrance increases with increasing age. 

Pulmonary Circulation
21 November 2024

Congenital heart defects (CHDs) represent one of the most prevalent categories of neonatal defects, and maternal dietary patterns have been linked to the risk of these conditions. Branched-chain amino acids (BCAAs), particularly leucine, are essential for various metabolic and physiological processes involved in heart development. In this study, we examined the molecular mechanisms through which elevated levels of leucine induce defects in cardiac microvascular endothelial cells.

Pulmonary Circulation
21 November 2024

To the editor,
Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare disease characterized by alveolar surfactant accumulation, progressive dyspnea, and hypoxemic respiratory insufficiency, and in some patients, secondary infections, pulmonary fibrosis, respiratory failure, and death.1 GM-CSF (granulocyte/macrophage colony-stimulating factor) autoantibodies cause aPAP by blocking GM-CSF signaling, which impairs alveolar macrophage functions including surfactant clearance.

Pulmonary Circulation
17 November 2024

Right ventricular (RV) (dys)function determines outcomes in pulmonary hypertension (PH). We previously found that asymmetric RV myocardial work (MW) corresponds with inefficient RV function in experimental PH models. We therefore aimed to investigate regional distribution of RV MW and its correlation with catheter hemodynamics in children with PH.

Pulmonary Circulation